辛伐他汀对大鼠肺纤维化及其内皮间质变过程的影响*

doi:10.12047/j.cjap.6120.2021.068

中国应用生理学杂志 ›› 2021, Vol. 37 ›› Issue (5): 454-459.doi: 10.12047/j.cjap.6120.2021.068

辛伐他汀对大鼠肺纤维化及其内皮间质变过程的影响^*

涂容芳^△+, 何振华⁺, 谭小武, 陈哲, 曾赛丽, 刘莎, 贾远航, 李雪花

南华大学衡阳医学院,附属第二医院,呼吸与危重症医学科, 湖南衡阳 421001

收稿日期:2020-07-06 修回日期:2021-01-27 出版日期:2021-09-28 发布日期:2021-11-24
通讯作者: ^△Tel: 15200738718; E-mail: 723372920@qq.com.
作者简介:⁺: 为共同第一作者
基金资助:
^*湖南省教育厅(18C0453)

Effects of simvastatin on pulmonary fibrosis and endothelial - mesenchymal transition in the pulmonary fibrosis tissue of rats

TU Rong-fang^△+, HE Zhen-hua⁺, TAN Xiao-wu, CHEN Zhe, ZENG Sai-li, LIU Sha, JIA Yuan-hang, LI Xue-hua

The Second Affiliated Hospital, Department of Pulmonary and Critical Care Medicine, Hengyang Medical School, University of South China, Hengyang 421001, China

Received:2020-07-06 Revised:2021-01-27 Online:2021-09-28 Published:2021-11-24

摘要/Abstract

摘要： 目的: 观察辛伐他汀对大鼠肺纤维化及其内皮间质变(EnMT )过程中VE-钙粘素(VE-cad)、波形蛋白(VIM)、α-平滑肌蛋白(α-SMA)表达的影响。方法: 健康雄性SD大鼠60只,随机分为对照组(A组)、造模组(B组)、辛伐他汀5 mg治疗组(C组)、辛伐他汀10 mg治疗组(D组),每组各15只。博来霉素(BLM)按5 mg/kg剂量一次性气管内灌注复制博莱霉素致大鼠肺纤维化模型,从造模第1日起C、D 组每天分别胃内灌注辛伐他汀混悬液5 mg /(kg·d)及辛伐他汀混悬液10 mg /(kg·d),A组和B 组每天胃内灌注等体积生理盐水10 ml /(kg·d)。于造模第7、14和28 日随机处死各组大鼠5只。Masson染色观察大鼠肺组织形态变化;碱性水解法检测肺组织中羟脯氨酸(HYP)含量;免疫组化法测定各组大鼠肺组织血管新生微血管密度(MVD);免疫组化和逆转录-聚合酶链反应法测定各组肺组织中VE-Cad、VIM及α-SMA蛋白和mRNA的表达水平。结果: ①与A组相比,B、C、D组各时间点肺组织HYP和MVD水平、VIM、α-SMA的mRNA和蛋白表达水平均明显升高(P均＜0.05),且以28 d达最高;而相应时间点VE-Cad 的mRNA和蛋白表达水平均明显降低(P均＜0.05),且以28 d达最低。②与B组相比,C、D组HYP和MVD水平、VIM、α-SMA的mRNA和蛋白表达水平均有降低(P均＜0.05),以D组28 d下降最明显;而相应时间点VE-Cad 的mRNA和蛋白表达水平均有升高(P均＜0.05),以D组28 d升高最明显。结论: 辛伐他汀可减轻大鼠肺纤维化,其机制可能与增强VE-cad表达,降低VIM及α-SMA表达,减少EnMT 发生有关。

关键词: 肺纤维化, 内皮间质转化, 辛伐他汀, 大鼠

Abstract: Objective: To investigate the effects of simvastatin (SIM) on pulmonary fibrosis and the expression of VE-cadherin(VE-cad),vimentin(VIM) and alpha-smooth muscle actin(α-SMA)in the pulmonary fibrosis tissue of rats. Methods: Sixty healthy male SD rats were randomly divided into control group(group A), bleomycin group(group B), 5 mg SIM group (group C) and 10 mg SIM group (group D),15 rats in each group. The model of rat pulmonary fibrosis was established by itraperitoneal injection of bleomycin(5 mg/kg). Since the first day of modeling, the rats of group C and D were treated with simvastatin suspension 5 mg/(kg·d) and 10 mg/(kg·d) by intragastric administration everyday, and the rats of group A and B were treated with equal volume of saline 10 ml/(kg·d) everyday. Five rats of each group were sacrificed randomly at the 7th, 14th and 28th day. Masson staining was used to observe the morphological changes of lung tissue in rats. The degree of fibrosis in lung tissues of each group was evaluated by the content of hydroxyproline (HYP) . The microvessel density (MVD) was analyzed by immunohistochemistry,The expressions of protein and mRNA of VE-cad, VIM and α-SMA were determined by immunohistochemistry and RT-PCR. Results: ①Compared with group A, the levels of HYP and MVD, the mRNA and protein expression levels of VIM and α-SMA in lung tissues of groups B, C and D were increased significantly at the 7th, 14th and 28th day(all P＜0.05), which reached highest level at the 28th day. However, the mRNA and protein expression levels of VE-CAD were decreased significantly at the corresponding time (P＜0.05), which reached lowest level at 28th day. ②Compared with group B, the levels of HYP and MVD, the mRNA and protein expression levels of VIM and α-SMA in groups C and D were decreased at the 7th, 14th and 28th day (all P＜0.05), which were decreased more obviously in group D at the 28th day. However, the mRNA and protein expression levels of VE-CAD were increased at the corresponding time (all P＜0.05), which were increased more obviously in group D at the 28th day. Conclusion: Simvastatin can reduce the degree of pulmonary fibrosis in rats through inhibiting the process of EnMT, which can enhance the expression of VE-cad and reduce the expression of VIM and α-SMA.

Key words: pulmonary fibrosis, endothelial-mesenchymal transition, simvastatin, rat

中图分类号:

R563.9

涂容芳, 何振华, 谭小武, 陈哲, 曾赛丽, 刘莎, 贾远航, 李雪花. 辛伐他汀对大鼠肺纤维化及其内皮间质变过程的影响^*[J]. 中国应用生理学杂志, 2021, 37(5): 454-459.

TU Rong-fang, HE Zhen-hua, TAN Xiao-wu, CHEN Zhe, ZENG Sai-li, LIU Sha, JIA Yuan-hang, LI Xue-hua. Effects of simvastatin on pulmonary fibrosis and endothelial - mesenchymal transition in the pulmonary fibrosis tissue of rats[J]. CJAP, 2021, 37(5): 454-459.

参考文献

[1] Wynn TA. Integrating mechanisms of pulmonary fibrosis[J]. J Exp Med, 2011, 208(7): 1339-1350.
[2] Gharaee-Kermani M, Gyetko MR, Hu B, et al. New insights into the pathogenesis and treatment of idiopathic pulmonary fibrosis: a potential role for stem cells in the lung parenchyma and implications for therapy[J]. Pharm Res, 2007, 24(5): 819-841.
[3] King TE Jr, Pardo A, Selman M. Idiopathic pulmonary fibrosis[J]. Lancet, 2011, 378(9807): 1949-1961.
[4] Hashimoto N, Phan SH, Imaizumi K, et al. Endothelial-mesenchymal transition in bleomycin-induced pulmonary fibrosis[J]. Am J Respir Cell Mol Biol, 2010, 43(2): 161-172.
[5] Kruzliak P, Hare DL, Zvonicek V, et al. Simvastatin impairs the induction of pulmonary fibrosis caused by a western style diet: a preliminary study[J]. J Cell Mol Med, 2015, 19(11): 2647-2654.
[6] WeisM, Heeschen C, Glassfo rd AJ, et al. Statins have biphasic effects on angiogenesis[J]. Circulation, 2002, 105 (6): 739-745.
[7] 田晟, 曹文富, 张永越, 等. 益气化瘀化痰方对肺纤维化大鼠的干预作用及其机制[J]. 中国应用生理学杂志, 2019, 35(2): 101-106.
[8] Singh S, Adam M, Matkar PN, et al. Endothelial-specific loss of IFT88 promotes endothelial-to-mesenchymal transition and exacerbates bleomycin- induced pulmonary fibrosis[J]. Sci Rep, 2020, 10(1): 1-14.
[9] Weinstein N, Mendoza L, Alvarez-Buylla ER. A computational model of the endothelial to mesenchymal transition[J]. Front Genet, 2020, 11: 40.
[10] Hulshoff MS, Xu X, Krenning G, et al. Epigenetic regulation of endothelial-to-mesenchymal transition in chronic heart disease[J]. Arterioscler Thromb Vasc Biol, 2018, 38(9): 1986-1996.
[11] Lu X, Gong J, Dennery PA, et al. Endothelial-to-mesenchymal transition: Pathogenesis and therapeutic targets for chronic pulmonary and vascular diseases[J]. Biochem Pharmacol, 2019, 168: 100-107.
[12] 蒋荣, 陈明霞. 二氧化硅诱导的内皮间质转化参与矽肺纤维化的实验研究[J]. 现代预防医学, 2020, 47(9): 1665-1669.
[13] Hashimoto N, Phan SH, Imaizumi K, et al. Endothelial-mesenchymal transition in bleomycin-induced pulmonary fibrosis[J]. Am J Respir Cell Mol Biol, 2010, 43(2): 161-172.
[14] Jiang Y, Zhou X, Hu R, et al. TGF-β1-induced SMAD 2/3/4 activation promotes RELM-β transcription to modulate the endothelium-mesenchymal transition in human endothelial cells[J]. Int J Biochem Cell Biol, 2018, 105: 52-60.
[15] Sabbineni H, Verma A, Somanath PR. Isoform-specific effects of transforming growth factor β on endothelial-to-mesenchymal transition[J]. J Cell Physiol, 2018, 233(11): 8418-8428.
[16] Piera-Velazquez S, Li Z, Jimenez SA. Role of endothelial-mesenchymal transition (EndoMT) in the pathogenesis of fibrotic disorders[J]. Am J Pathol, 2011, 179 (3): 1074-1080.
[17] 涂容芳, 张秀峰, 何振华. 5-HTR2B、E-cad、α-SMA在博莱霉素致大鼠肺纤维化中的表达变化[J]. 中国应用生理学杂志, 2016, 32(4): 365-369.

辛伐他汀对大鼠肺纤维化及其内皮间质变过程的影响^*

Effects of simvastatin on pulmonary fibrosis and endothelial - mesenchymal transition in the pulmonary fibrosis tissue of rats

PDF (PC)

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 15

编辑推荐

Metrics

本文评价

[1]	黄燕云, 高洁, 张利娜, 杜相欣, 张雨彤, 郭霞, 郝娜, 李建国, 张宇. 利用全细胞膜片钳技术记录大鼠脑片NMDA电流的研究^*[J]. 中国应用生理学杂志, 2021, 37(5): 459-462.
[2]	丁茂鹏, 韦凌霞, 王志旺, 程小丽, 庞亚蓉. 鳖甲育肝颗粒对复合因素所致肝纤维化大鼠TGF-β1/Smads通路的影响^*[J]. 中国应用生理学杂志, 2021, 37(5): 463-467.
[3]	吴经纬, 王一蓉, 陈伟, 刘文锋. 不同训练方式对大鼠骨骼肌纤维类型转化和CaMK II/MEF2传导途径的影响^*[J]. 中国应用生理学杂志, 2021, 37(5): 470-474.
[4]	许骥, 方以群, 包晓辰, 袁恒荣, 王楠, 王芳芳. 核辐射对大深度快速上浮脱险致减压病大鼠相关指标的影响^*[J]. 中国应用生理学杂志, 2021, 37(5): 486-489.
[5]	张瑜, 路青华, 曹海芳, 张生荣, 王虎德. GPR81激动剂对非酒精性脂肪肝病大鼠胰岛素抵抗的影响[J]. 中国应用生理学杂志, 2021, 37(4): 354-358.
[6]	丁海丽, 黄增浩, 任在方, 孙竹昕, 李俊平, 王瑞元. 针刺对大鼠运动性骨骼肌损伤内质网应激的干预作用及机制[J]. 中国应用生理学杂志, 2021, 37(4): 359-364.
[7]	杨向君, 王羽, E.巴雅日玛, 赵明, S.贺希格扎日嘎拉. 蒙药绍沙-7味丸防治大鼠心肌缺血/再灌注损伤的作用[J]. 中国应用生理学杂志, 2021, 37(4): 380-384.
[8]	郝卯林, 楼国强, 刘秀洁, 钱巍, 王嘉, 周卓琳, 王万铁. 细胞自噬在大鼠缺血/再灌注肺损伤中的调控作用[J]. 中国应用生理学杂志, 2021, 37(4): 385-388.
[9]	刘雪枫, 乔婧, 高建德, 陈正君, 刘雄. 党参总皂苷对TNBS诱导的大鼠溃疡性结肠炎的保护作用及其机制[J]. 中国应用生理学杂志, 2021, 37(4): 397-401.
[10]	耿元文, 林琴琴, 王湘怡, 李若明, 田振军. 间歇运动对心梗大鼠心肌氧化应激和炎症的影响及其机制[J]. 中国应用生理学杂志, 2021, 37(4): 439-444.
[11]	郜慧英, 周艳, 高洁, 李颜君, 孙向荣. 糖尿病大鼠弓状核-海马肥胖抑素通路构成及对胃运动和胃排空的影响[J]. 中国应用生理学杂志, 2021, 37(3): 230-234.
[12]	张换鸽, 胡柏平. 跑台运动对攻击行为大鼠内侧下丘脑和中脑导水管周围灰质5-HT1A受体、5-HT2A受体蛋白表达的影响[J]. 中国应用生理学杂志, 2021, 37(3): 272-275.
[13]	张桃, 谢雅, 陈颖, 夏德尧, 赵方毓, 陈显兵, 樊孝琼. 筒鞘蛇菰提取物蛇菰多糖对D-半乳糖诱导大鼠肝损伤的保护作用及其机制[J]. 中国应用生理学杂志, 2021, 37(3): 276-280.
[14]	王品, 曹建民, 胡戈, 周海涛, 张静, 郭娴, 牛衍龙, 程鑫云, 李嘉蓓. 姜黄素对过度训练大鼠脾脏炎症反应的调控作用及其机制[J]. 中国应用生理学杂志, 2021, 37(3): 281-286.
[15]	王友华, 陈伟, 马美, 戴高远, 滑艺杰. 不同强度有氧运动对大鼠房室结形态结构及VEGF、VIP、Syn表达的影响[J]. 中国应用生理学杂志, 2021, 37(3): 287-292.